Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:40:38.766Z.
Calculation as of: 2026-10-06T16:40:38.766Z.
Quote observation: 2026-10-06T16:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125
PEG RATIO
N/A
Akanda Corp.
Market Cap
$61819.00
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71496.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95000.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108604.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6210.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $244081.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $389228.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $685948.00 | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
